StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
ESOPApr 21, 2026, 04:12 PM

Autolus Grants 126,265 Stock Options & RSUs to 15 New Employees

AI Summary

Autolus Therapeutics plc announced that its Compensation Committee granted a total of 126,265 equity awards to 15 new employees. These awards include 68,500 stock options and 57,765 restricted stock units (RSUs), issued under the Company's 2025 Inducement Plan to attract new talent. The stock options have an exercise price of $1.47 per share and, along with the RSUs, will vest over four years, contingent on continued employment.

Key Highlights

  • Granted 68,500 stock options and 57,765 restricted stock units (RSUs).
  • Awards issued to 15 new employees under the 2025 Inducement Plan.
  • Stock options have an exercise price of $1.47 per share.
  • Both stock options and RSUs vest over four years.